Topic
Cancer
-
Aug 27, 2026
Early Signs and Symptoms of Leukemia in Adults
Early leukemia symptoms like fatigue, easy bruising, and frequent infections are common and usually benign, so persistent or unexplained ones deserve a clinician evaluation.
-
Aug 27, 2026
Early Signs and Symptoms of Ovarian Cancer
Ovarian cancer symptoms are subtle and easy to dismiss. Learn the signs worth a prompt clinician visit, why CA-125 alone is a poor screen, and where personalized detection fits.
-
Aug 27, 2026
Early Signs and Symptoms of Pancreatic Cancer
Pancreatic cancer symptoms are vague and easy to miss. Learn which signs deserve a prompt clinician visit and where blood-based early detection fits for people at higher risk.
-
Aug 27, 2026
LucenceINSIGHT vs. GRAIL Galleri: MCED Cancer Tests Compared
How LucenceINSIGHT and GRAIL Galleri compare for multi-cancer early detection, including how each works, cancer coverage, panel choices, origin prediction, and shared limits.
-
Aug 27, 2026
How Ancestry, Genetics, and Aging Shape Your Cancer Risk
Population averages are not your personal odds. Ancestry, inherited genes, exposures, and age each shift cancer risk, and they point to what to screen for.
-
Aug 27, 2026
Multi-Cancer Blood Test: What It Costs and How to Get One
A multi-cancer blood test needs a clinician order and is rarely covered by insurance. Here is what drives the price and how to get one through Mito's telehealth path.
-
Aug 27, 2026
What Is a Multi-Cancer Early Detection (MCED) Test?
A multi-cancer early detection test looks for signals from many cancers in one blood draw. It is a screening adjunct, not a diagnosis, and does not replace guideline screening.
-
Aug 21, 2026
Personalized mRNA Melanoma Vaccine Reports Positive Phase 3 Results
Merck and Moderna say intismeran plus pembrolizumab improved two measures of melanoma recurrence after surgery, but the full Phase 3 data are not yet public.
-
Oct 1, 2025
Mitochondria and Cancer: What Damage Does to Tumors and What You Can Do
Damaged mitochondria change how tumors grow and spread. See how dysfunction affects cancer metabolism, signs to watch for, and steps to support healthier cells.
Screening lab tests
Prostate-Specific Antigen (PSA), Free and Total Blood Test
Adds the free-to-total ratio that helps tell benign prostate enlargement from cancer when total PSA is borderline.
PSA, Total Blood Test with Reflex to PSA, Free
The main prostate screening marker, tracking changes that can signal enlargement, inflammation, or cancer.
Complete Blood Count (CBC) with Differential and Platelet Count Test
A broad screen of red cells, white cells, and platelets that anchors most checkups.
Comprehensive Metabolic Panel (CMP)
A 14-marker snapshot of kidney function, liver function, electrolytes, and blood sugar in one draw.